<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title42.html">
                                    Title 42
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/42CFR410.html">Part 410
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 410.30  Prescription drugs used in immunosuppressive therapy.
                            </h3>
                            <p class="depth1"><em>(a)</em> Scope. Payment may be made for prescription drugs used in  immunosuppressive therapy that have been approved for marketing by the  FDA and that meet one of the following conditions:</p><p class="depth2"><em>(1)</em> The approved labeling includes the indication for preventing or  treating the rejection of a transplanted organ or tissue.</p><p class="depth2"><em>(2)</em> The approved labeling includes the indication for use in  conjunction with immunosuppressive drugs to prevent or treat rejection  of a transplanted organ or tissue.</p><p class="depth2"><em>(3)</em> Have been determined by a carrier (in accordance with part 421,  subpart C of this chapter), in processing a Medicare claim, to be  reasonable and necessary for the specific purpose of preventing or  treating the rejection of a patient's transplanted organ or tissue, or  for use in conjunction with immunosuppressive drugs for the purpose of  preventing or treating the rejection of a patient's transplanted organ  or tissue. (In making these determinations, the carriers may consider  factors such as authoritative drug compendia, current medical  literature, recognized standards of medical practice, and professional  medical publications.)</p><p class="depth1"><em>(b)</em> Eligibility. For drugs furnished on or after December 21, 2000,  coverage is available only for prescription drugs used in  immunosuppressive therapy, furnished to an individual who received an  organ or tissue transplant for which Medicare payment is made, provided  the individual is eligible to receive Medicare Part B benefits.</p><p class="depth1"><em>(c)</em> Coverage. Drugs are covered under this provision irrespective of  whether they can be self-administered.  [60 FR 8955, Feb. 16, 1995. Redesignated at 63 FR 34327, June 24, 1998;  74 FR 62002, Nov. 25, 2009]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
